Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 3,566 shares at $2.17 ($8K) on 2022-08-04, disclosed to the SEC on 2022-08-19.
Scheduled purchase ($8k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.11 | 130 | $274 | 3.3% |
| 2 | $2.18 | 144 | $314 | 3.8% |
| 3 | $2.11 | 144 | $304 | 3.7% |
| 4 | $2.18 | 144 | $314 | 3.8% |
| 5 | $2.19 | 144 | $315 | 3.8% |
| 6 | $2.25 | 144 |
| $324 |
| 3.9% |
| 7 | $2.28 | 144 | $328 | 4.0% |
| 8 | $2.23 | 144 | $321 | 3.9% |
| 9 | $2.41 | 124 | $299 | 3.6% |
| 10 | $2.47 | 124 | $306 | 3.7% |
| 11 | $2.52 | 124 | $312 | 3.8% |
| 12 | $2.54 | 124 | $315 | 3.8% |
| 13 | $2.53 | 124 | $314 | 3.8% |
| 14 | $2.48 | 124 | $308 | 3.7% |
| 15 | $2.47 | 124 | $306 | 3.7% |
| 16 | $2.36 | 90 | $212 | 2.6% |
| 17 | $2.28 | 124 | $283 | 3.4% |
| 18 | $2.28 | 124 | $283 | 3.4% |
| 19 | $2.34 | 124 | $290 | 3.5% |
| 20 | $2.45 | 50 | $123 | 1.5% |
| 21 | $2.17 | 124 | $269 | 3.3% |
| 22 | $2.12 | 124 | $263 | 3.2% |
| 23 | $2.19 | 138 | $302 | 3.7% |
| 24 | $2.19 | 138 | $302 | 3.7% |
| 25 | $2.19 | 138 | $302 | 3.7% |
| 26 | $2.46 | 138 | $339 | 4.1% |
| 27 | $2.52 | 138 | $348 | 4.2% |
| 28 | $2.45 | 110 | $270 | 3.3% |
| Total | $2.31 avg | 3,566 | $8K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |